Autobio Diagnostics (603658.SH) has announced that it has recently received medical devices registration certificates issued by the Henan Provincial Drug Administration. It has obtained a total of 14 medical device registration certificates, further enriching the company's product menu, continuously meeting market demands and effectively supplementing the company's existing testing products. This can gradually improve the overall competitiveness of the company's products, and its impact on the company's business performance in the short term is minimal.
Futu Inc. β Highlights for 2Q21: Net income of $151.0 million, up 602.8% YoY Net revenue of $292.5 million, up 129.5% YoY Total paying clients reached 1.98 million, up 151.8% YoY Assets under custody of $46.1 billion as of June 30, 2021, up 104.8% YoY. Futu Inc. (NASDAQ: FUTU) is an advanced technology company transforming the investing experience for users by offering a fully digitized brokerage and wealth management platform, and a suite of premier, internet-based trading services.